Marshall Wace’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,000
Closed -$1.06M 3303
2025
Q4
$1.06M Buy
+24,000
New +$1.35M ﹤0.01% 1893
2025
Q1
Sell
-58,867
Closed -$3.14M 2723
2024
Q4
$3.14M Buy
+58,867
New +$2.88M ﹤0.01% 1270
2024
Q2
Sell
-84,200
Closed -$2.27M 2630
2024
Q1
$2.27M Buy
+84,200
New +$2.4M ﹤0.01% 1304
2023
Q4
Sell
-128,169
Closed -$2.72M 2259
2023
Q3
$2.72M Buy
+128,169
New +$3.5M 0.01% 1087
2023
Q2
Sell
-343,886
Closed -$11.1M 2564
2023
Q1
$11.1M Buy
343,886
+73,914
+27% +$2.45M 0.02% 677
2022
Q4
$9.06M Buy
269,972
+164,833
+157% +$5.03M 0.02% 858
2022
Q3
$3.18M Buy
+105,139
New +$3.85M 0.01% 1707

Other funds holding DOCS

Marshall Wace's DOCS Position: Q1 2026 in Review

Marshall Wace sold out of Doximity (DOCS) in Q1 2026, closing a stake of 24,000 shares — an estimated $1.06M sold.

Marshall Wace first reported a position in DOCS in Q3 2022 and held it in 7 quarters. The position peaked at $11.1M in Q1 2023. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Marshall Wace reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 24,000 Doximity shares in Q1 2026, an estimated $1.06M.
  • Marshall Wace first reported a position in Doximity in Q3 2022 and held it in 7 quarters.
  • Marshall Wace's Doximity position peaked at $11.1M in Q1 2023.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.